SYK

Stryker Corporation

Healthcare
295.00 +1.70 +0.58% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 113.09B
EV —
Shares Out 383.36M
Revenue (ttm) 25.27B
Net Income 3.34B
Beta —
P/E 33.85
Forward P/E —
EPS (ttm) $8.64
P/S 4.47
P/B 4.92
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 7.21%
ROE 15.11%
ROIC 9.47%
Gross Margin 63.83%
Oper. Margin 19.74%
Profit Margin 13.21%
Debt/Eq 0.66
LT Debt/Eq 38.23%
Quick Ratio —
Current Ratio 2.11
Book/sh 60.01
Cash/sh 7.52
Div Yield 1.15%
Div TTM $3.40
Payout Ratio 39.35%
SMA20 -2.73%
SMA50 -7.29%
SMA200 -16.96%
Volume 2,189,099
Avg Volume 2.37M
Rel Volume —
Perf Week -3.31%
Perf Month -0.08%
Perf Quarter -20.38%
Perf Half Y -18.96%
Perf YTD -16.07%
Perf Year -23.00%
Perf 3Y 6.13%
Perf 5Y 17.14%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.8800
TTM Yield 1.15%
TTM Amount $3.40
Payout Ratio 39.35%
3-Yr Growth (CAGR) —
5-Yr Growth (CAGR) —

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.8800
Q3 2025 ~2025-09-30 $0.8400
Q2 2025 ~2025-06-30 $0.8400
Q1 2025 ~2025-03-31 $0.8400
Q3 2024 ~2024-09-30 $0.8000
Q2 2024 ~2024-06-30 $0.8000
Q1 2024 ~2024-03-31 $0.8000
Q3 2023 ~2023-09-30 $0.7500
Q2 2023 ~2023-06-30 $0.7500
Q1 2023 ~2023-03-31 $0.7500
Q3 2022 ~2022-09-30 $0.6950
Q2 2022 ~2022-06-30 $0.6950

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Stryker Corporation is a global leader in medical technologies that together with its customers is driven to make healthcare better. The Company offers innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Stryker's products are sold in approximately 61 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors. The product portfolio includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and artificial intelligence-assisted virtual care platform technology; products for traditional brain and open skull-based surgical procedures; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; implants used in joint replacement and trauma surgeries; Mako robotic-arm assisted technology; and other products used in a variety of medical specialties. Most products are marketed directly to doctors, hospitals and other healthcare facilities.

Name
Stryker Corporation
Industry
Medical Devices
CEO
Kevin A. Lobo · Chair and Chief Executive Officer
Employees
43,000 as of 2025-12-31
IPO Date
2017-02-07
Phone
(269) 385-2600
Address
1941 Stryker Way, Portage, MI 49002
Website
www.stryker.com

Key Executives

Name Title FY Pay
Viju S. Menon Executive Vice President, Operations and Supply Chain —
J. Andrew Pierce Group President, MedSurg and Neurotechnology —
Spencer S. Stiles Group President, Orthopaedics —
Preston W. Wells Chief Financial Officer —
Kevin A. Lobo Chair and Chief Executive Officer —

Latest News